Characteristics | N | % |
---|---|---|
Age group | ||
 5-17a | 20,174 | 1.96 |
 18–44 | 252,790 | 24.60 |
 45–64 | 281,177 | 27.37 |
 65–74 | 94,779 | 9.23 |
  ≥ 75 | 79,894 | 7.78 |
 Unknown | 298,591 | 29.06 |
Sex group | ||
 Male | 309,665 | 30.14 |
 Female | 665,950 | 64.82 |
 Unknown | 51,790 | 5.04 |
WHO reporting area | ||
 Africa | 3507 | 0.34 |
 Americas | ||
  United States | 594,543 | 57.87 |
  Canada | 44,079 | 4.29 |
  Other countries | 5549 | 0.54 |
 Asia | ||
  China | 9827 | 0.96 |
  India | 8284 | 0.81 |
  Japan | 7722 | 0.75 |
  Singapore | 1012 | 0.10 |
  South Korea | 15,919 | 1.55 |
  Other countries | 5863 | 0.57 |
Europe | ||
  France | 45,142 | 4.39 |
  Germany | 36,334 | 3.54 |
  Italy | 16,180 | 1.57 |
  United Kingdom | 99,131 | 9.65 |
  Other countries | 97,238 | 9.46 |
 Oceania | ||
  Australia | 30,210 | 2.94 |
  New Zealand | 6865 | 0.67 |
Notifier type | ||
  Physicians | 310,728 | 30.24 |
  Pharmacists | 65,062 | 6.33 |
  Other health professionals | 84,365 | 8.21 |
  Patients | 238,572 | 23.22 |
  Hospitals | 38,922 | 3.79 |
  Lawyers | 13,372 | 1.30 |
  Drugs companies | 6470 | 0.63 |
  Others | 124,913 | 12.16 |
  Unknown | 145,001 | 14.11 |
Serious cases | ||
  Yes | 385,788 | 37.55 |
  No | 300,879 | 29.29 |
  Unknown | 340,738 | 33.16 |